Inhibitory effect of insulin on bradykinin-induced venodilation

Journal of Hypertension

Volumn 18, Issue 3, 2000, Pages 287-292

  Kimura, Masahiko ^a   Watanabe, Hiroshi ^a   Takahashi, Reiko ^a   Kosuge, Kazuhiro ^a   Umemura, Kazuo ^a   Hayashi, Hideharu ^a   Ohashi, Kyoichi ^a   Ohno, Ryuzo ^a  

^a Department of Clinical Pharmacology ^*

Author keywords

Bradykinin; Dorsal hand vein; Endothelium; Hyperinsulinaemia; Insulin; Insulin resistance; Intracellular calcium

Indexed keywords

BRADYKININ; CALCIUM; INSULIN;

ADULT; ANIMAL CELL; AORTA; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; DIABETES MELLITUS; DRUG ANTAGONISM; DRUG INHIBITION; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VEIN DILATATION;

EID: 0034010819     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018030-00008     Document Type: Article

References (34)

1. 1 Auch-Schwelk W, Kuchenbuch C, Claus M, Walther B, Bossaller C, Friedel N, et al. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors. Eur Heart J 1993; 14:154-160.
2. 2 Baron AD, Clark MG. Role of blood flow in the regulation of muscle glucose uptake. Ann Rev Nutr 1997; 17:487-499.
3. 3 Steinberg HO, Brachtel G, Johnson A, Fineberg N, Baron AD. Insulinmediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94:1172-1179.
4. 4 Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994; 94:2511-2515.
5. 5 Sowers JR, Standley PR, Ram JL, Jacober S, Simpson L, Rose K. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993; 6:260S-270S.
6. 6 Afonso LC, Edelson GW, Sowers JR. Metabolic abnormalities in hypertension. Curr Opin Nephrol Hypertens 1997; 6:219-223.
7. 7 Edelson GW, Sowers JR. Insulin resistance in hypertension: a focused review. Am J Med Sci 1993; 306:345-347.
8. 8 Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994; 267:E187-E202.
9. 9 Feldman RD, Bierbrier GS. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet 1993; 342:707-709.
10. 10 de Haan CH, van Dielen FM, Houben AJ, de Leeuw PW, Huvers FC, De Mey JG, et al. Peripheral blood flow and noradrenaline responsiveness: the effect of physiological hyperinsulinemia. Cardiovasc Res 1997; 34:192-198.
11. 11 Vischer UM. Insulin resistance and the regulation of vascular tone: is insulin a vasodilator? Eur J Endocrinol 1998; 138:262-263.
12. 12 Hausberg M, Hoffman RP, Somers VK, Sinkey CA, Mark AL, Anderson EA. Contrasting autonomic and hemodynamic effects of insulin in healthy elderly versus young subjects. Hypertension 1997; 29:700-705.
13. 13 Kimura M, Umemura K, Kosuge K, Nishimoto M, Ohashi K, Nakashima M. Attenuation by ACE inhibitor drugs of alpha-adrenoceptor sensitivity in human vessels: possible differences related to drug lipophilicity. Br J clin Pharmacol 1998; 46:599-603.
14. 14 Kohlman O Jr, Neves FDA, Ginoza M, Tavares A, Cezaretti ML, Zanella MT, et al. Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemia. Hypertension 1995; 25:1003-1007.
15. 15 Taddei S, Virdis A, Ghiadoni L, Uleri S, Magagna A, Salvetti A. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension 1997; 30:1606-1612.
16. 16 Aellig WH. A new technique for recording compliance of human hand veins. Br J Clin Pharmacol 1981; 11:237-243.
17. 17 Dachman WD, Ford GA, Blaschke TF, Hoffman BB. Mechanism of brady-kinin-induced venodilation in humans. J Cardiovasc Pharmacol 1993; 21:241-248.
18. 2+ influx in endothelial cells. FASEB J 1998; 12:341-348.
19. 19 Li Q, Altschuld RA, Stokes BT. Quantitation of intracellular free calcium in single adult cardiomyocytes by fura-2 fluorescence microscopy: calibration of fura-2 ratios. Biochem Biophys Res Commun 1987; 147:120-126.
20. 20 DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol 1978; 235:E97-E102.
21. 21 Qadir E, Porter JP. Effect of insulin on regional vascular resistances in conscious rats. Am J Physiol 1996; 270:R450-R455.
22. 22 Stepniakowski KT, Lu G, Miller GD, Egan BM. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins. Hypertension 1997; 30:1150-1155.
23. 23 Mendelowitz D, Bacal K, Kunze DL. Bradykinin-activated calcium influx pathway in bovine aortic endothelial cells. Am J Physiol 1992; 262:H942-H948.
24. 24 Freay A, Johns A, Adams DJ, Ryan US, Van Breemen C. Bradykinin and inositol 1, 4, 5-trisphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells. Pflugers Arch 1989; 414:377-384.
25. 25 Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993; 361:315-325.
26. 26 Tsien RW, Tsien RY. Calcium channels, stores, and oscillations. Annu Rev Cell Biol 1990; 6:715-760.
27. 27 Putney JW Jr, Bird GS. The inositol phosphate-calcium signaling system in nonexcitable cells. Endocr Rev 1993; 14:610-631.
28. 2+ ions or a staurosporine-sensitive kinase. Br J Pharmacol 1993; 110:411-415.
29. 2+ and nitric oxide in bradykinin-stimulated vascular endothelial cells. Circul Res 1995; 76:922-924.
30. 30 Bauersachs J, Popp R, Hecker M, Sauer E, Fleming l, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996; 94:3341-3347.
31. 31 Parsaee H, McEwan J, Joseph S, Dermot J. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells. Br J Pharmacol 1992; 107:1013-1019.
32. 32 Fleming I, Fisslthaler B, Busse R. Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circul Res 1995; 76:522-529.
33. 33 Haring HU, Tippmer S, Kellerer M, Mosthaf L, Kroder G, Bossenmaier B, et al. Modulation of insulin receptor signaling. Potential mechanisms of a cross talk between bradykinin and the insulin receptor. Diabetes 1996; 45:S115-S119.
34. 34 Vincent J, Blaschke TF, Hoffman BB. Vascular reactivity to phenylephrine and angiotensin II: comparison of direct venous and systemic vascular responses. Clin Pharmacol Ther 1992; 51:68-75.